Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis

NCT03198689 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Collaborators